Bristol-Myers Squibb are currently the only supplier of these products and they are facing manufacturing difficulties. Further supplies of Questran Light are expected in early July and Questran at the end of July. Importers have indicated that unlicensed supplies are available from other countries. This memo advises on alternative treatment options in the interim.
Update (17 May 2019): This memo is currently being updated as the supply situation of the Questran products and of the alternative treatment options have changed. Currenty, there is shortage of Questran but Questran Light is now available, on emergency/restricted supply basis via Alliance Healthcare. Sanofi is out of stock of colesevelam until week commencing 17 June. Details of supply situation of colestipol is being confirmed.
Medicines Information Pharmacist, London and South East Regional Medicines Information